SPDR S&P Telecom ETF(XTL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

XTL SPDR S&P Telecom ETF

Post-Mkt 06-17 16:05:37 EDT

221.49

-2.54

-1.13%

盘后221.49

+0.000.00%

16:04 EDT

High225.63	Low221.23	Vol118.88K
Open224.56	D1 Closing224.03	Amplitude1.97%
Mkt Cap764.14M	Tradable Cap764.14M	Total Shares3.45M
T/O26.58M	T/O Rate3.45%	Tradable Shares3.45M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"XTL","market":"US","secType":"STK","nameCN":"SPDR S&P Telecom ETF","latestPrice":221.49,"timestamp":1781726400000,"preClose":224.03,"halted":0,"volume":118882,"hourTrading":{"tag":"盘后","latestPrice":221.49,"preClose":221.49,"latestTime":"16:04 EDT","volume":565,"amount":125141.85,"timestamp":1781726691413,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.011337767263312913,"floatShares":3450000,"shares":3450000,"eps":0,"marketStatus":"Post-Mkt","change":-2.54,"latestTime":"06-17 16:05:37 EDT","open":224.56,"high":225.63,"low":221.2265,"amount":26575463.61298,"amplitude":0.019656,"askPrice":0,"askSize":0,"bidPrice":214.3,"bidSize":4,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1781740800000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":224.03,"sharesOutstanding":1625000,"nav":231.094266,"aum":791497862.57,"dividendRate":0.008901,"bidAskSpread":0.00136,"postHourTrading":{"tag":"盘后","latestPrice":221.49,"preClose":221.49,"latestTime":"16:04 EDT","volume":565,"amount":125141.85,"timestamp":1781726691413,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.725965,"impliedVol":0.2939,"impliedVolPercentile":0.8327},"requestUrl":"/m/hq/s/XTL/wiki","defaultTab":"wiki","newsList":[{"id":"1108840859","title":"SpaceX's Wireless Ambitions May Not Disrupt US Telecoms Soon, BNP Paribas Analysis Suggests","url":"https://stock-news.laohu8.com/highlight/detail?id=1108840859","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108840859?lang=en_us&edition=fundamental","pubTime":"2026-06-15 08:59","pubTimestamp":1781485144,"startTime":"0","endTime":"0","summary":"According to a research report released by BNP Paribas on June 12, SpaceX's long-term wireless communication strategy may be more complex than many investors currently perceive, and its potential to...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1571399168.USD","SPCU","LU1066051225.USD","LU0265550359.USD","SPCX","UFO","LU0868494617.USD","SPCH","LU1066051811.HKD","LU1066053197.SGD","BK4588","BK4581","SPAL","LU0225771236.USD","LU0985481810.HKD","LU2433249047.HKD","LU2210149790.SGD","LU1621768115.EUR","LU1699723380.USD","LU0306807586.USD","LU1366192091.USD","LU2125909593.SGD","LU2095319765.USD","IE00BSNM7G36.USD","XTL","BK4533","LU1162221912.USD","LU1116320737.USD","BK4089","LU1066051498.USD","DXYZ","LU0225284248.USD","LU0320765646.SGD","LU0868494708.USD","LU1116320901.HKD","LU1621767737.EUR","LU0321505868.SGD","LU0306806265.USD","BK4550","LU2125909247.SGD","LU2381873111.SGD","LU0098860793.USD","LU0321505439.SGD","LU1585245621.USD","LU1621767810.EUR","XOVR","LU0265550946.USD","SNK","LOFF","LU0942090050.USD","LU1923622614.USD","LU2210150020.SGD","BK4115","BK4534","BK4585","BK4615","LU1430594728.SGD","HK0000819398.USD","VZ","LU1059921491.USD","BK4559","SPCF","LU2384288077.EUR","LU1621768206.USD","BK4515","LU1914381329.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637207344","title":"XTL Biopharmaceuticals Gets Nasdaq Noncompliance Notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2637207344","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637207344?lang=en_us&edition=fundamental","pubTime":"2026-05-23 04:42","pubTimestamp":1779482560,"startTime":"0","endTime":"0","summary":"XTL Biopharmaceuticals  received a letter from Nasdaq for not complying with its listing rules after failing to file its 2025 Form 20-F annual report, the company said late Friday.The company is also facing a Nasdaq Hearings Panel review for not meeting the minimum $2.5 million stockholders' equity and $1 bid price listing requirements.These issues could lead to a potential delisting, and the company has until May 26 to request a stay of the suspension of its securities, it said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NQmain","BK4139","XTL","XTLB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637344275","title":"XTL Biopharmaceuticals Faces Added Nasdaq Delisting Risk Over Late 2025 Annual Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2637344275","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637344275?lang=en_us&edition=fundamental","pubTime":"2026-05-23 04:27","pubTimestamp":1779481678,"startTime":"0","endTime":"0","summary":"XTL Biopharmaceuticals Sponsored ADR ( ($XTLB) ) has provided an update. On May 22, 2026, XTL Biopharmaceuticals disclosed that it received a Nasda...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-faces-added-nasdaq-delisting-risk-over-late-2025-annual-report?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-faces-added-nasdaq-delisting-risk-over-late-2025-annual-report?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XTL","NQmain","XTLB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637634455","title":"XTL Announces Receipt of Staff Delist Determination from Nasdaq","url":"https://stock-news.laohu8.com/highlight/detail?id=2637634455","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637634455?lang=en_us&edition=fundamental","pubTime":"2026-05-23 04:10","pubTimestamp":1779480600,"startTime":"0","endTime":"0","summary":"RAMAT GAN, ISRAEL, May  22, 2026  (GLOBE NEWSWIRE) --  XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced today that it has received a letter (the “Letter”) f","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/22/3300353/0/en/XTL-Announces-Receipt-of-Staff-Delist-Determination-from-Nasdaq.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4077","XTLB","SLE","XTL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635953053","title":"XTL Biopharmaceuticals Calls June 22, 2026 Meeting to Approve Psyga Bio Acquisition and Capital Raise","url":"https://stock-news.laohu8.com/highlight/detail?id=2635953053","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635953053?lang=en_us&edition=fundamental","pubTime":"2026-05-16 05:38","pubTimestamp":1778881080,"startTime":"0","endTime":"0","summary":"An update from XTL Biopharmaceuticals Sponsored ADR ( ($XTLB) ) is now available. XTL Biopharmaceuticals Ltd. said on May 15, 2026 that it has call...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-calls-june-22-2026-meeting-to-approve-psyga-bio-acquisition-and-capital-raise?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-calls-june-22-2026-meeting-to-approve-psyga-bio-acquisition-and-capital-raise?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XTL","BK4139","XTLB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635790036","title":"The stock market is breaking the rules of the inflation playbook. Here is what is different this time","url":"https://stock-news.laohu8.com/highlight/detail?id=2635790036","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635790036?lang=en_us&edition=fundamental","pubTime":"2026-05-14 17:38","pubTimestamp":1778751480,"startTime":"0","endTime":"0","summary":"A look at which assets are following the script, and which aren't, on day 75 of the war. This screen grab taken from undated video footage released by Iran's Revolutionary Guards  and made available via Iran's state broadcaster  on April 23, 2026, shows IRGC naval forces allegedly boarding a ship attempting to cross the Strait of Hormuz. TD Securities finds that bonds have behaved as expected during an inflationary shock.There's nothing financial market participants like more than round numbers, and on day 75 of the war on Iran it's worth looking at how financial markets are behaving versus other big crises.Izidor Flajsman, senior rates strategist at TD Securities, ran an update to the firm's analysis of big inflation shocks in the past and what happened in markets.Fixed-income - shown both on the chart, as well as a more detailed breakdown of corporate credit and other maturities of U.S. government bond - is behaving like it has in previous inflationary outbreaks. Data released by the","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XTL","BK4585","XRT","XLK","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635979096","title":"A look at which assets are following the script, and which aren't, on day 75 of the war","url":"https://stock-news.laohu8.com/highlight/detail?id=2635979096","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635979096?lang=en_us&edition=fundamental","pubTime":"2026-05-14 17:29","pubTimestamp":1778750940,"startTime":"0","endTime":"0","summary":"This screen grab taken from undated video footage released by Iran's Revolutionary Guards  and made available via Iran's state broadcaster  on April 23, 2026, shows IRGC naval forces allegedly boarding a ship attempting to cross the Strait of Hormuz. TD Securities finds that bonds have behaved as expected during an inflationary shock.There's nothing financial market participants like more than round numbers, and on day 75 of the war on Iran it's worth looking at how financial markets are behaving versus other big crises.Izidor Flajsman, senior rates strategist at TD Securities, ran an update to the firm's analysis of big inflation shocks in the past and what happened in markets.The chart here shows what's behaving like the past and what is not:. Gold  and silver   also are not following the inflation playbook, but both had surged ahead of the Iran war.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLK","BK4588","XTL","BK4585","XRT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633123887","title":"XTL Biopharmaceuticals Wins Conditional Nasdaq Listing Reprieve Tied to Psyga Bio Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2633123887","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633123887?lang=en_us&edition=fundamental","pubTime":"2026-05-07 21:38","pubTimestamp":1778161139,"startTime":"0","endTime":"0","summary":"XTL Biopharmaceuticals Sponsored ADR ( ($XTLB) ) has shared an announcement. On April 16, 2026, XTL Biopharmaceuticals’ management and counsel appe...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-wins-conditional-nasdaq-listing-reprieve-tied-to-psyga-bio-deal?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-wins-conditional-nasdaq-listing-reprieve-tied-to-psyga-bio-deal?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","XTL","XTLB","NQmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631517095","title":"XTL Biopharmaceuticals to Acquire PsygaBio in All-Stock Deal to Expand Psychedelic Drug Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2631517095","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631517095?lang=en_us&edition=fundamental","pubTime":"2026-04-29 21:36","pubTimestamp":1777469775,"startTime":"0","endTime":"0","summary":"XTL Biopharmaceuticals Sponsored ADR ( ($XTLB) ) just unveiled an update. On April 28, 2026, XTL Biopharmaceuticals Ltd. signed a definitive share ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-to-acquire-psygabio-in-all-stock-deal-to-expand-psychedelic-drug-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-to-acquire-psygabio-in-all-stock-deal-to-expand-psychedelic-drug-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","XTL","XTLB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631512824","title":"XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2631512824","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631512824?lang=en_us&edition=fundamental","pubTime":"2026-04-29 20:58","pubTimestamp":1777467480,"startTime":"0","endTime":"0","summary":"Transaction Positions XTL at the Forefront of the Rapidly Expanding Global Psychedelic Therapeutics Market Following Major U.S. Regulatory Momentum Seven Approved Phase 2a Human Clinical Trials Expect","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/29/3283784/0/en/XTL-Biopharmaceuticals-to-Acquire-Psyga-Bio-Establishing-a-Leading-Psychedelic-Biotechnology-Platform-with-Advanced-Clinical-Pipeline-Licensed-GMP-Manufacturing-and-Proprietary-Psi.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1815336091.USD","BK4077","IE00B7SZL793.SGD","XTLB","BK4157","AEIS","IE00B19Z4B17.USD","IE0031619046.USD","XTL","IE00B66KJ199.SGD","BK4139","SLE","LU0757428866.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622701498","title":"XTL Biopharmaceuticals trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2622701498","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622701498?lang=en_us&edition=fundamental","pubTime":"2026-03-25 07:50","pubTimestamp":1774396233,"startTime":"0","endTime":"0","summary":"19:50 EDT XTL Biopharmaceuticals (XTLB) trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving b...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/xtl-biopharmaceuticals-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/xtl-biopharmaceuticals-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XTL","BK4139","XTLB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621751741","title":"XTL Biopharmaceuticals to Change ADS Ratio","url":"https://stock-news.laohu8.com/highlight/detail?id=2621751741","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621751741?lang=en_us&edition=fundamental","pubTime":"2026-03-21 04:34","pubTimestamp":1774038844,"startTime":"0","endTime":"0","summary":"XTL Biopharmaceuticals (XTLB) said late Friday it plans to change the ratio of its American Depositary Shares to 1 ADS to 400 shares from 1 ADS to 100 shares, effective March 25.The ratio change will have the same effect as a 1-for-4 reverse ADS split for its ADS holders, the company said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XTL","BK4139","XTLB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621754885","title":"XTL Biopharmaceuticals to Implement One-for-Four ADS Reverse Split Effective March 25, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2621754885","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621754885?lang=en_us&edition=fundamental","pubTime":"2026-03-21 04:27","pubTimestamp":1774038440,"startTime":"0","endTime":"0","summary":"The latest update is out from XTL Biopharmaceuticals Sponsored ADR ( ($XTLB) ). On March 20, 2026, XTL Biopharmaceuticals announced it will change ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-to-implement-one-for-four-ads-reverse-split-effective-march-25-2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-to-implement-one-for-four-ads-reverse-split-effective-march-25-2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XTLB","BK4139","XTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618937396","title":"Beyond Air announces termination of NeuroNOS agreement with XTL","url":"https://stock-news.laohu8.com/highlight/detail?id=2618937396","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618937396?lang=en_us&edition=fundamental","pubTime":"2026-03-10 19:35","pubTimestamp":1773142543,"startTime":"0","endTime":"0","summary":"Beyond Air (XAIR) announced that the previously disclosed proposed transaction with XTL Biopharmaceuticals (XTLB) relating to Beyond Air’s NeuroNOS...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beyond-air-announces-termination-of-neuronos-agreement-with-xtl-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beyond-air-announces-termination-of-neuronos-agreement-with-xtl-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XAIR","XTL","BK4139","BK4082","XTLB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614827898","title":"XTL Biopharmaceuticals Faces Nasdaq Delisting After “Public Shell” Determination","url":"https://stock-news.laohu8.com/highlight/detail?id=2614827898","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614827898?lang=en_us&edition=fundamental","pubTime":"2026-02-28 06:00","pubTimestamp":1772229653,"startTime":"0","endTime":"0","summary":"An update from XTL Biopharmaceuticals Sponsored ADR ( ($XTLB) ) is now available. On February 27, 2026, XTL Biopharmaceuticals disclosed that Nasda...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-faces-nasdaq-delisting-after-public-shell-determination?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-faces-nasdaq-delisting-after-public-shell-determination?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","XTL","XTLB","NQmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614867286","title":"XTL Biopharmaceuticals gets delisting letter from Nasdaq, to request hearing","url":"https://stock-news.laohu8.com/highlight/detail?id=2614867286","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614867286?lang=en_us&edition=fundamental","pubTime":"2026-02-28 05:35","pubTimestamp":1772228158,"startTime":"0","endTime":"0","summary":"XTL Biopharmaceuticals (XTLB) announced that it has received a letter from Nasdaq, dated February 25, notifying the company of the staff’s belief, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/xtl-biopharmaceuticals-gets-delisting-letter-from-nasdaq-to-request-hearing-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/xtl-biopharmaceuticals-gets-delisting-letter-from-nasdaq-to-request-hearing-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NQmain","XTL","XTLB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614677898","title":"XTL Announces Receipt of Staff Delist Determination from Nasdaq and Plans to Request Hearing","url":"https://stock-news.laohu8.com/highlight/detail?id=2614677898","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614677898?lang=en_us&edition=fundamental","pubTime":"2026-02-28 05:30","pubTimestamp":1772227800,"startTime":"0","endTime":"0","summary":"RAMAT GAN, ISRAEL, Feb.  27, 2026  (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced today that it has received a letter (the “Letter”) f","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/27/3246813/0/en/XTL-Announces-Receipt-of-Staff-Delist-Determination-from-Nasdaq-and-Plans-to-Request-Hearing.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLE","XTL","XTLB","BK4139","BK4077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606371755","title":"XTL Biopharmaceuticals Advances NeuroNOS Acquisition and Plans $2 Million Private Placement to Address Nasdaq Equity Deficiency","url":"https://stock-news.laohu8.com/highlight/detail?id=2606371755","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606371755?lang=en_us&edition=fundamental","pubTime":"2026-01-28 22:17","pubTimestamp":1769609841,"startTime":"0","endTime":"0","summary":"The latest announcement is out from XTL Biopharmaceuticals Sponsored ADR ( ($XTLB) ). On January 28, 2026, XTL Biopharmaceuticals Ltd. announced it...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-advances-neuronos-acquisition-and-plans-2-million-private-placement-to-address-nasdaq-equity-deficiency?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-advances-neuronos-acquisition-and-plans-2-million-private-placement-to-address-nasdaq-equity-deficiency?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XTLB","NQmain","BK4588","BK4139","BK4585","EQR","BK4215","XTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605612286","title":"XTL Biopharmaceuticals Faces Subsidiary Insolvency Filing, Reviews $1.5 Million Loan Exposure","url":"https://stock-news.laohu8.com/highlight/detail?id=2605612286","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605612286?lang=en_us&edition=fundamental","pubTime":"2026-01-24 06:11","pubTimestamp":1769206267,"startTime":"0","endTime":"0","summary":"XTL Biopharmaceuticals Sponsored ADR ( ($XTLB) ) just unveiled an update. On January 23, 2026, XTL Biopharmaceuticals reported that its wholly owne...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-faces-subsidiary-insolvency-filing-reviews-1-5-million-loan-exposure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-faces-subsidiary-insolvency-filing-reviews-1-5-million-loan-exposure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XTL","BK4139","XTLB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605286646","title":"XTL Biopharmaceuticals Flags Nasdaq Equity Deficiency, Given Deadline to Regain Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2605286646","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605286646?lang=en_us&edition=fundamental","pubTime":"2026-01-24 06:10","pubTimestamp":1769206256,"startTime":"0","endTime":"0","summary":"XTL Biopharmaceuticals Sponsored ADR ( ($XTLB) ) has provided an announcement. On January 23, 2026, XTL Biopharmaceuticals disclosed that it receiv...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-flags-nasdaq-equity-deficiency-given-deadline-to-regain-compliance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-flags-nasdaq-equity-deficiency-given-deadline-to-regain-compliance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","NQmain","BK4139","BK4215","XTL","XTLB","BK4585","EQR"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://us.spdrs.com/en/product/fund.seam?ticker=XTL","stockEarnings":[{"period":"1week","weight":0.0141},{"period":"1month","weight":-0.0083},{"period":"3month","weight":0.1909},{"period":"6month","weight":0.5262},{"period":"1year","weight":1.0665},{"period":"ytd","weight":0.4621}],"compareEarnings":[{"period":"1week","weight":0.018},{"period":"1month","weight":0.0151},{"period":"3month","weight":0.1344},{"period":"6month","weight":0.1092},{"period":"1year","weight":0.245},{"period":"ytd","weight":0.1003}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"In seeking to track the performance of the S&P Telecom Select Industry Index (the \"index\"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the telecommunications segment of the S&P Total Market Index (\"S&P TMI\").","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.012129},{"month":2,"riseRate":0.5625,"avgChangeRate":0.017738},{"month":3,"riseRate":0.375,"avgChangeRate":-0.008067},{"month":4,"riseRate":0.5,"avgChangeRate":0.002597},{"month":5,"riseRate":0.75,"avgChangeRate":0.013241},{"month":6,"riseRate":0.5625,"avgChangeRate":0.007542},{"month":7,"riseRate":0.666667,"avgChangeRate":0.027862},{"month":8,"riseRate":0.533333,"avgChangeRate":0.010685},{"month":9,"riseRate":0.4,"avgChangeRate":-0.020678},{"month":10,"riseRate":0.666667,"avgChangeRate":0.01893},{"month":11,"riseRate":0.733333,"avgChangeRate":0.027279},{"month":12,"riseRate":0.533333,"avgChangeRate":0.009135}],"exchange":"ARCA","name":"SPDR S&P Telecom ETF","nameEN":"SPDR S&P Telecom ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SPDR S&P Telecom ETF(XTL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest SPDR S&P Telecom ETF(XTL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"SPDR S&P Telecom ETF,XTL,SPDR S&P Telecom ETF股票,SPDR S&P Telecom ETF股票老虎,SPDR S&P Telecom ETF股票老虎国际,SPDR S&P Telecom ETF行情,SPDR S&P Telecom ETF股票行情,SPDR S&P Telecom ETF股价,SPDR S&P Telecom ETF股市,SPDR S&P Telecom ETF股票价格,SPDR S&P Telecom ETF股票交易,SPDR S&P Telecom ETF股票购买,SPDR S&P Telecom ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SPDR S&P Telecom ETF(XTL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest SPDR S&P Telecom ETF(XTL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction